Home News

IV Ketamine 101

Intravenous (IV) ketamine is used as a treatment option for various mental health conditions, particularly treatment-resistant depression (TRD). Here’s an overview of the use of

IV ketamine is administered directly into the bloodstream through an intravenous line, typically in a controlled medical setting. The dosage and infusion rate are determined based on the individual’s condition and response to treatment.

IV ketamine has gained attention as a rapid-acting antidepressant, often producing a quick and significant reduction in depressive symptoms. Many individuals who have not responded to traditional antidepressant medications may experience an improvement in their mood and overall well-being after IV ketamine treatment.

IV ketamine is particularly useful in treating TRD, which refers to depression that has not responded adequately to multiple trials of different antidepressant medications. It offers an alternative treatment option for individuals who have not found relief through conventional therapies.

A typical course of IV ketamine treatment for depression involves a series of sessions. The frequency of sessions can vary but is often initially scheduled close together, such as two or three times per week, and then spaced out over time as maintenance treatment. The duration of treatment also depends on the individual’s response and clinical judgment.

Ketamine treatment, including IV administration, can be associated with certain side effects. These may include dissociative experiences (feeling disconnected from oneself or one’s surroundings), changes in perception, dizziness, nausea, and transient increases in blood pressure and heart rate. However, these effects are generally temporary and resolve soon after the infusion.

IV ketamine treatment requires careful monitoring and supervision by trained healthcare professionals. The individual’s vital signs, such as blood pressure and heart rate, are regularly monitored during and after the infusion. The treatment setting is designed to ensure the individual’s safety and well-being throughout the process.

Apart from depression, IV ketamine is also being explored as a potential treatment for other psychiatric conditions, such as post-traumatic stress disorder (PTSD), bipolar disorder, and certain anxiety disorders. However, more research is needed to determine its efficacy and safety in these specific conditions.

It is essential to consult with a qualified healthcare professional or psychiatrist to discuss the potential benefits, risks, and considerations of IV ketamine treatment. They can evaluate an individual’s specific condition, treatment history, and determine if IV ketamine is an appropriate treatment option in their case.